https://www.selleckchem.com/products/tas-120.html
Participants completed a mean 11.0 (SD 4.4; 79%) of 14 PP-MI phone sessions, and composite mean ratings of ease/utility were 8.6/10, above our a priori benchmarks for feasibility/acceptability (70% session completion; 7.0/10 mean ratings). PP-MI participants had small to medium effect size (ES) difference improvements in MVPA (ES difference=0.34) and steps/day (ES difference=0.76) at 16weeks, with sustained but smaller effects at 24weeks (ES difference=0.22-0.33). Next-step studies of this PP-MI program in T2D patients can more rigorous